CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
OPERATING ACTIVITIES
Net loss	$ (41,205)	$ (19,700)
Adjustments
Depletion, depreciation and amortization	743	757
Accretion expense	975	768
Share-based payments	692	530
Non-cash items included in other expense (income)	17,564	(4,405)
Loss on foreign exchange	123	69
Interest expense	8,204	8,030
Deferred tax expense	0	386
Other	34	(80)
Net change in operating assets and liabilities	(9,831)	(11,578)
Cash used in operating activities	(22,701)	(25,223)
INVESTING ACTIVITIES
Capital expenditures on property, plant and equipment	(356)	(702)
Cash used in investing activities	(356)	(702)
FINANCING ACTIVITIES
Share issue costs	(113)	(380)
Stock option exercises	8	586
Finance fees paid	(294)	(200)
Other	(16)	(125)
Cash provided by financing activities	18,316	17,317
Change in cash, cash equivalents and restricted cash during the period	(4,741)	(8,608)
Cash, cash equivalents and restricted cash, beginning of period	59,290	60,765
Effect of exchange rate changes on cash held	(126)	(69)
Cash, cash equivalents and restricted cash, end of period	54,423	52,088
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents	13,475	13,090
Restricted cash and cash equivalents	40,948	38,998
Total cash, cash equivalents, and restricted cash	54,423	52,088
Equity Financing
FINANCING ACTIVITIES
Proceeds from share issued	16,212	17,436
ATM Program
FINANCING ACTIVITIES
Proceeds from share issued	$ 2,519	$ 0